PD39 - Application of population pharmacokinetic modeling and simulation in the design of the optimal dose regime of rupatadine in children 2-5 year old children
SourceClinical and Translational Allergy, 4, Suppl 1 3rd Pediatric Allergy and Asthma Meeting (PAAM)Publi, (2014), pp. P39
Article / Letter to editor
Display more detailsDisplay less details
Clinical and Translational Allergy
iss. Suppl 1 3rd Pediatric Allergy and Asthma Meeting (PAAM)Publi
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.